announcement, page-6

re: what now? I think the short-term drop in price is a result of the delay in announcing the Hep E deal which should have been announced by now according to previous announcements.

Today''s announcement made reference to it

'The company is currently finalising arrangements in respect of the recently announced deal covering the
Hepatitis E virus diagnostic test. Further announcements in relation to this and progress in respect of the
development of the Hepatitis C rapid diagnostic test are expected shortly.'

but am a little surprised they didn't mention whether Genelabs testing has been completed as it should have by the end of October.

You can probably understand a few jitters, but it does look by the price action, that even confirmation of that deal won't move SLT shareprice to great heights. A longer-term view needs to be taken, it appears.

Cheers